Cernelle is a pharmaceutical company with research, development, manufacture and distribution of medicine in urology; chronic prostatitis/pelvic pain syndrome (CP/CPPS) and benign prostate enlargement (BPH).
Founded 1953 in Sweden, Cernelle was first to extract, process and purify pollen grains for medical use. The extracting methods were further developed to extract pollen in large scales and to produce, the today worldwide established, Cernitin™ pollen extracts. With endless curiosity and strong determination, we have set out to accelerate our leadership in extracting and purifying pollen grains in products for medical use.
Cernelle is located in the rural area Vegeholm in southern Sweden, where fields and pastures create a patchwork rich in colours and scents. This is where it all began, and this is where we will continue to evolve and build a prosperous future.”
In order to manage the ongoing expansion and growth , Cernelle expects to recruit 25-30 talented and skilled people the upcoming years.
Company Details
- Employees
- 30
- Founded
- -
- Address
- Höganäsvägen 365, Ängelholm,26294,sweden
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- cernelle.com
- HQ
- Ängelholm
Ab Cernelle Questions
Ab Cernelle's website is cernelle.com
Ab Cernelle's LinkedIn profile is https://se.linkedin.com/company/ab-cernelle
Ab Cernelle has
30 employees.
View email and phone details for 30
employees at Ab Cernelle.
Ab Cernelle's industry is
Pharmaceutical Manufacturing
Ab Cernelle's top competitors are
Niconovum Ab,
Ot Chemistry,
Nordic Drugs,
Ascelia Pharma Ab,
Mcneil Ab I Helsingborg,
Maverick Enterprise,
Tekemas A/s & Ab,
Hemocue Ab,
Camurus,
Allergon Ab.
Ab Cernelle's categories are Pharmaceutical Manufacturing
Ab Cernelle's founding year is 1953
